135 related articles for article (PubMed ID: 26718170)
1. A Rare Pancreatic Tumor That Underwent a Change in Morphology and Histopathologic Features During Chemotherapy.
Seino S; Tsuchiya A; Natsui M
Gastroenterology; 2016 Feb; 150(2):e11-3. PubMed ID: 26718170
[No Abstract] [Full Text] [Related]
2. [A case of pancreatic acinar cell carcinoma with a giant liver metastasis successfully treated with combination of gemcitabine and peroral S-1].
Nishimizu T; Minemura M; Kajiura S; Tokimitsu Y; Itaya Y; Yamawaki H; Kawai K; Tajiri K; Nakayama Y; Hosokawa A; Takahara T; Yasumura S; Shimizu S; Fukuoka J; Ishizawa S; Sawasaki T; Yanagisawa A; Sugiyama T
Gan To Kagaku Ryoho; 2011 Feb; 38(2):309-12. PubMed ID: 21368502
[TBL] [Abstract][Full Text] [Related]
3. Four cases of pancreatic acinar cell carcinoma treated with gemcitabine or S-1 as a single agent.
Seki Y; Okusaka T; Ikeda M; Morizane C; Ueno H
Jpn J Clin Oncol; 2009 Nov; 39(11):751-5. PubMed ID: 19666905
[TBL] [Abstract][Full Text] [Related]
4. Poorly differentiated neuroendocrine carcinoma of the pancreas responsive to combination therapy with gemcitabine and S-1.
Yamamoto M; Miyagawa K; Hiura M; Taguchi M; Kihara Y; Abe S; Shimajiri S; Harada M
Intern Med; 2012; 51(7):727-32. PubMed ID: 22466828
[TBL] [Abstract][Full Text] [Related]
5. A case report of mixed acinar-endocrine carcinoma of the pancreas treated with S-1 chemotherapy: Does it work or induce endocrine differentiation?
Yokode M; Itai R; Yamashita Y; Zen Y
Medicine (Baltimore); 2017 Nov; 96(45):e8534. PubMed ID: 29137060
[TBL] [Abstract][Full Text] [Related]
6. [A case of advanced pancreatic cancer successfully treated by combined chemotherapy of S-1 and gemcitabine].
Kawasaki H; Kukita K; Mizushima Y; Hirata K
Gan To Kagaku Ryoho; 2008 Jul; 35(7):1239-42. PubMed ID: 18633272
[TBL] [Abstract][Full Text] [Related]
7. [A case of advanced pancreatic cancer responding to combination chemotherapy with the individual maximum repeatable dose of gemcitabine and oral S-1].
Fujimoto C; Maruyama Y; Niina Y; Fujimori N; Sumii T; Funakoshi A
Gan To Kagaku Ryoho; 2008 Jun; 35(6):1013-6. PubMed ID: 18633236
[TBL] [Abstract][Full Text] [Related]
8. [A case of liver metastasis of pancreatic acinar cell carcinoma treated with S-1 and intra-arterial CDDP combination therapy].
Fujii M; Sato H; Ogasawara T; Ando T; Tsujii S; Nagahori J; Komatsu Y; Matsuoka A
Gan To Kagaku Ryoho; 2010 Oct; 37(10):1987-90. PubMed ID: 20948270
[TBL] [Abstract][Full Text] [Related]
9. [A case of complete response of gemcitabine (GEM) monotherapy-refractive liver metastatic pancreatic cancer treated with GEM+S-1 combined chemotherapy].
Hatata T; Takaya S; Taniguchi K; Naka T; Kondo A; Ikeguchi M
Gan To Kagaku Ryoho; 2011 Jan; 38(1):109-12. PubMed ID: 21368469
[TBL] [Abstract][Full Text] [Related]
10. A case of gemcitabine-refractory pancreatic cancer responsive to second-line chemotherapy using S-1.
Morizane C
Jpn J Clin Oncol; 2007 Dec; 37(12):973. PubMed ID: 18211987
[No Abstract] [Full Text] [Related]
11. [Effective combination chemotherapy with gemcitabine hydrochloride, S-1 and nedaplatin for recurrent pancreatic cancer--a case report].
Tokairin Y; Iida M; Yamazaki S
Gan To Kagaku Ryoho; 2008 Nov; 35(12):2123-5. PubMed ID: 19106544
[TBL] [Abstract][Full Text] [Related]
12. [The progress of chemotherapy for advanced pancreatic cancer].
Ioka T; Katayama K; Ashida R; Takahashi H; Teshima T; Sakon M
Nihon Shokakibyo Gakkai Zasshi; 2015 Dec; 112(12):2119-26. PubMed ID: 26638783
[No Abstract] [Full Text] [Related]
13. [S-1+gemcitabine (GEM) therapy was effective in a case of unresectable pancreatic head carcinoma].
Takada J; Okuda K; Kenno S; Shimada S; Oba G; Shimokuni T; Aoki T; Hamada H
Gan To Kagaku Ryoho; 2008 Nov; 35(12):2120-2. PubMed ID: 19106543
[TBL] [Abstract][Full Text] [Related]
14. [Usefulness of S-1/gemcitabine combination therapy for advanced pancreatic cancer].
Hara T; Nagata M; Yamashita Y; Fujimoto K; Muraki Y; Yasuda Y; Kurahashi T
Gan To Kagaku Ryoho; 2008 Jul; 35(7):1233-7. PubMed ID: 18633271
[TBL] [Abstract][Full Text] [Related]
15. The impact of body composition on short-term outcomes of neoadjuvant chemotherapy with gemcitabine plus S-1 in patients with resectable pancreatic cancer.
Takeda T; Sasaki T; Mie T; Furukawa T; Yamada Y; Kasuga A; Matsuyama M; Ozaka M; Sasahira N
Jpn J Clin Oncol; 2021 Apr; 51(4):604-611. PubMed ID: 33479765
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic Acinar Cell Carcinoma with Multiple Liver Metastases Effectively Treated by S-1 Chemotherapy.
Yoshida N; Kanno A; Masamune A; Nabeshima T; Hongo S; Miura S; Takikawa T; Hamada S; Kikuta K; Kume K; Ueno M; Shimosegawa T
Intern Med; 2018 Dec; 57(24):3529-3535. PubMed ID: 30101903
[TBL] [Abstract][Full Text] [Related]
17. [A case of advanced pancreatic cancer responding well to S-1/gemcitabine combination therapy after gemcitabine therapy].
Kuji M; Yamamoto Y; Tani C; Kenno S; Kobayashi T
Gan To Kagaku Ryoho; 2011 May; 38(5):853-5. PubMed ID: 21566453
[TBL] [Abstract][Full Text] [Related]
18. [A case of recurrent pancreatic cancer with lung metastasis responding to S-1 combined gemcitabine chemotherapy].
Fukada I; Ikeda H; Yamaguchi K; Okabe M; Tsuruta A; Morimoto Y; Kawamoto K; Sano K; Paku T; Imai S; Yoshida Y; Ito T; Ogasahara K
Gan To Kagaku Ryoho; 2009 Oct; 36(10):1733-6. PubMed ID: 19838037
[TBL] [Abstract][Full Text] [Related]
19. Randomized phase II/III trial of neoadjuvant chemotherapy with gemcitabine and S-1 versus upfront surgery for resectable pancreatic cancer (Prep-02/JSAP05).
Motoi F; Kosuge T; Ueno H; Yamaue H; Satoi S; Sho M; Honda G; Matsumoto I; Wada K; Furuse J; Matsuyama Y; Unno M;
Jpn J Clin Oncol; 2019 Feb; 49(2):190-194. PubMed ID: 30608598
[TBL] [Abstract][Full Text] [Related]
20. [S-1+gemcitabine (GEM) therapy effective in a case of pancreatic body cancer with multiple liver metastasis].
Fukui H; Kou C; Matsumoto T; Matsumoto M
Gan To Kagaku Ryoho; 2010 Sep; 37(9):1775-8. PubMed ID: 20841945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
